tiprankstipranks
Trending News
More News >
STRATEC Biomedical (GB:0RAR)
:0RAR
UK Market
Advertisement

STRATEC Biomedical (0RAR) Financial Statements

Compare
1 Followers

STRATEC Biomedical Financial Overview

STRATEC Biomedical's market cap is currently €348.88M. The company's EPS TTM is €; its P/E ratio is 21.71; and it has a dividend yield of 2.09%. STRATEC Biomedical is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 257.62M€ 261.91M€ 274.63M€ 287.33M€ 250.10M
Gross Profit€ 76.39M€ 64.84M€ 79.49M€ 87.71M€ 68.99M
Operating Income€ 28.18M€ 29.14M€ 40.01M€ 48.18M€ 32.48M
EBITDA€ 47.34M€ 43.16M€ 57.53M€ 66.52M€ 56.72M
Net Income€ 16.02M€ 15.37M€ 29.22M€ 39.96M€ 25.18M
Balance Sheet
Cash & Short-Term Investments€ 48.73M€ 34.22M€ 24.07M€ 48.72M€ 39.15M
Total Assets€ 445.06M€ 466.58M€ 397.50M€ 368.52M€ 331.90M
Total Debt€ 130.53M€ 141.37M€ 87.15M€ 85.30M€ 109.58M
Net Debt€ 83.37M€ 107.84M€ 64.48M€ 38.11M€ 72.02M
Total Liabilities€ 202.53M€ 233.25M€ 172.32M€ 162.77M€ 159.36M
Stockholders' Equity€ 242.53M€ 233.33M€ 225.18M€ 205.76M€ 172.54M
Cash Flow
Free Cash Flow€ 30.52M€ 2.00M€ -8.74M€ 43.24M€ 6.27M
Operating Cash Flow€ 48.71M€ 19.43M€ 10.28M€ 63.47M€ 31.85M
Investing Cash Flow€ -15.97M€ -44.16M€ -19.00M€ -20.13M€ -21.84M
Financing Cash Flow€ -20.30M€ 35.44M€ -14.11M€ -34.33M€ 5.22M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

STRATEC Biomedical Debt to Assets

STRATEC Biomedical Cash Flow

STRATEC Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis